We've found
180
archived clinical trials in
Hair Loss
We've found
180
archived clinical trials in
Hair Loss
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Updated: 12/31/1969
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated: 12/31/1969
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Updated: 12/31/1969
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Updated: 12/31/1969
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated: 12/31/1969
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Updated: 12/31/1969
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Updated: 12/31/1969
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated: 12/31/1969
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Updated: 12/31/1969
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Tolerability of Hair Stimulating Complex (HSC) in Female Pattern Hair Loss
Updated: 12/31/1969
Phase 1, Randomized, Double-Blind, Vehicle-Controlled Study of Safety and Tolerability of Hair Stimulating Complex (HSC) in Female Subjects With Female Pattern Hair Loss
Status: Enrolling
Updated: 12/31/1969
Safety and Tolerability of Hair Stimulating Complex (HSC) in Female Pattern Hair Loss
Updated: 12/31/1969
Phase 1, Randomized, Double-Blind, Vehicle-Controlled Study of Safety and Tolerability of Hair Stimulating Complex (HSC) in Female Subjects With Female Pattern Hair Loss
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
The Effect of Platelet Rich Plasma on Non-scarring Alopecia
Updated: 12/31/1969
The Effect of Platelet Rich Plasma on Non-scarring Alopecia
Status: Enrolling
Updated: 12/31/1969
The Effect of Platelet Rich Plasma on Non-scarring Alopecia
Updated: 12/31/1969
The Effect of Platelet Rich Plasma on Non-scarring Alopecia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy Study of Tempol to Prevent Hair Loss From Radiotherapy to the Brain
Updated: 12/2/2008
Phase II Double-Blind, Placebo-Controlled Study of the Safety and Preliminary Effectiveness of MTS-01 for the Prevention of Alopecia Induced by Whole Brain Radiotherapy
Status: Enrolling
Updated: 12/2/2008
Efficacy Study of Tempol to Prevent Hair Loss From Radiotherapy to the Brain
Updated: 12/2/2008
Phase II Double-Blind, Placebo-Controlled Study of the Safety and Preliminary Effectiveness of MTS-01 for the Prevention of Alopecia Induced by Whole Brain Radiotherapy
Status: Enrolling
Updated: 12/2/2008
Click here to add this to my saved trials
Efficacy Study of Tempol to Prevent Hair Loss From Radiotherapy to the Brain
Updated: 12/2/2008
Phase II Double-Blind, Placebo-Controlled Study of the Safety and Preliminary Effectiveness of MTS-01 for the Prevention of Alopecia Induced by Whole Brain Radiotherapy
Status: Enrolling
Updated: 12/2/2008
Efficacy Study of Tempol to Prevent Hair Loss From Radiotherapy to the Brain
Updated: 12/2/2008
Phase II Double-Blind, Placebo-Controlled Study of the Safety and Preliminary Effectiveness of MTS-01 for the Prevention of Alopecia Induced by Whole Brain Radiotherapy
Status: Enrolling
Updated: 12/2/2008
Click here to add this to my saved trials
Safety and Efficacy of Clobetasol Propionate 0.05% E Foam in Alopecia
Updated: 4/27/2010
Safety and Efficacy of Clobetasol Propionate 0.05% E Foam in the Treatment of Central Centrifugal Cicatricial Alopecia
Status: Enrolling
Updated: 4/27/2010
Safety and Efficacy of Clobetasol Propionate 0.05% E Foam in Alopecia
Updated: 4/27/2010
Safety and Efficacy of Clobetasol Propionate 0.05% E Foam in the Treatment of Central Centrifugal Cicatricial Alopecia
Status: Enrolling
Updated: 4/27/2010
Click here to add this to my saved trials
Enhancing Hair Density With Platelet Rich Fibrin Matrix (PRFM)
Updated: 5/16/2012
Enhancing Hair Density With Platelet Rich Fibrin Matrix (PRFM)
Status: Enrolling
Updated: 5/16/2012
Enhancing Hair Density With Platelet Rich Fibrin Matrix (PRFM)
Updated: 5/16/2012
Enhancing Hair Density With Platelet Rich Fibrin Matrix (PRFM)
Status: Enrolling
Updated: 5/16/2012
Click here to add this to my saved trials
Safety and Efficacy of Bimatoprost Solution in Treating Eyelash Loss or Hypotrichosis in Children
Status: Enrolling
Updated: 5/29/2012
Updated: 5/29/2012
Safety and Efficacy of Bimatoprost Solution in Treating Eyelash Loss or Hypotrichosis in Children
Status: Enrolling
Updated: 5/29/2012
Updated: 5/29/2012
Click here to add this to my saved trials
Childhood Alopecia Areata Study Using the 308-nm Excimer Laser
Updated: 11/21/2012
Childhood Alopecia Areata Study: Part 1: Feasibility of the 308-nm Excimer Laser in Treatment of Patch Type Alopecia Areata in Pediatric Patients
Status: Enrolling
Updated: 11/21/2012
Childhood Alopecia Areata Study Using the 308-nm Excimer Laser
Updated: 11/21/2012
Childhood Alopecia Areata Study: Part 1: Feasibility of the 308-nm Excimer Laser in Treatment of Patch Type Alopecia Areata in Pediatric Patients
Status: Enrolling
Updated: 11/21/2012
Click here to add this to my saved trials
Alopecia Areata Registry and Immunogenetic Mechanisms
Updated: 11/20/2013
Alopecia Areata Registry and Immunogenetic Mechanisms
Status: Enrolling
Updated: 11/20/2013
Alopecia Areata Registry and Immunogenetic Mechanisms
Updated: 11/20/2013
Alopecia Areata Registry and Immunogenetic Mechanisms
Status: Enrolling
Updated: 11/20/2013
Click here to add this to my saved trials
Vytorin in the Treatment of Alopecia Areata
Updated: 7/30/2014
A Pilot Study To Evaluate the Efficacy of Vytorin (Simvastatin +Ezetimibe) In the Treatment of Alopecia Areata
Status: Enrolling
Updated: 7/30/2014
Vytorin in the Treatment of Alopecia Areata
Updated: 7/30/2014
A Pilot Study To Evaluate the Efficacy of Vytorin (Simvastatin +Ezetimibe) In the Treatment of Alopecia Areata
Status: Enrolling
Updated: 7/30/2014
Click here to add this to my saved trials
An Open-Label Single-Arm Clinical Trial to Evaluate The Efficacy of Abatacept in Moderate to Severe Patch Type Alopecia Areata
Updated: 1/26/2016
An Open-Label Single-Arm Clinical Trial to Evaluate The Efficacy of Abatacept in Moderate to Severe Patch Type Alopecia Areata
Status: Enrolling
Updated: 1/26/2016
An Open-Label Single-Arm Clinical Trial to Evaluate The Efficacy of Abatacept in Moderate to Severe Patch Type Alopecia Areata
Updated: 1/26/2016
An Open-Label Single-Arm Clinical Trial to Evaluate The Efficacy of Abatacept in Moderate to Severe Patch Type Alopecia Areata
Status: Enrolling
Updated: 1/26/2016
Click here to add this to my saved trials
A Safety and Efficacy Study of Bimatoprost in Men With Androgenic Alopecia (AGA)
Status: Enrolling
Updated: 2/23/2016
Updated: 2/23/2016
A Safety and Efficacy Study of Bimatoprost in Men With Androgenic Alopecia (AGA)
Status: Enrolling
Updated: 2/23/2016
Updated: 2/23/2016
Click here to add this to my saved trials
Combined Restylane and Triamcinolone Acetonide Injections for the Treatment of Alopecia Areata
Updated: 3/31/2016
Safety and Efficacy of Combined Restylane and Triamcinolone Acetonide Injections for the Treatment of Alopecia Areata
Status: Enrolling
Updated: 3/31/2016
Combined Restylane and Triamcinolone Acetonide Injections for the Treatment of Alopecia Areata
Updated: 3/31/2016
Safety and Efficacy of Combined Restylane and Triamcinolone Acetonide Injections for the Treatment of Alopecia Areata
Status: Enrolling
Updated: 3/31/2016
Click here to add this to my saved trials
Bimatoprost Ophthalmic Solution in Increasing Eyebrow and Eyelash Growth in Patients Who Have Undergone Chemotherapy for Breast Cancer and in Healthy Participants
Updated: 4/6/2016
Efficacy of Topical Bimatoprost in Promoting Hair Growth in the Region of the Eyebrow and Eyelashes for Post-chemotherapy Patients Versus Normal Patients
Status: Enrolling
Updated: 4/6/2016
Bimatoprost Ophthalmic Solution in Increasing Eyebrow and Eyelash Growth in Patients Who Have Undergone Chemotherapy for Breast Cancer and in Healthy Participants
Updated: 4/6/2016
Efficacy of Topical Bimatoprost in Promoting Hair Growth in the Region of the Eyebrow and Eyelashes for Post-chemotherapy Patients Versus Normal Patients
Status: Enrolling
Updated: 4/6/2016
Click here to add this to my saved trials
Pilot Study to Evaluate the Efficacy of Ruxolitinib in Alopecia Areata
Updated: 10/27/2016
An Open-Label Pilot Study to Evaluate the Efficacy of Ruxolitinib in Moderate to Severe Alopecia Areata
Status: Enrolling
Updated: 10/27/2016
Pilot Study to Evaluate the Efficacy of Ruxolitinib in Alopecia Areata
Updated: 10/27/2016
An Open-Label Pilot Study to Evaluate the Efficacy of Ruxolitinib in Moderate to Severe Alopecia Areata
Status: Enrolling
Updated: 10/27/2016
Click here to add this to my saved trials
Yoga-Based Rehabilitation Program in Reducing Physical and Emotional Side Effects in Patients With Cancer
Updated: 1/23/2017
Evaluation of a Yoga-Based Cancer Rehabilitation Program
Status: Enrolling
Updated: 1/23/2017
Yoga-Based Rehabilitation Program in Reducing Physical and Emotional Side Effects in Patients With Cancer
Updated: 1/23/2017
Evaluation of a Yoga-Based Cancer Rehabilitation Program
Status: Enrolling
Updated: 1/23/2017
Click here to add this to my saved trials
Study To Evaluate The Efficacy Of Tofacitinib In Moderate To Severe Alopecia Areata, Totalis And Universalis
Updated: 2/14/2017
An Open-Label Pilot Study To Evaluate The Efficacy Of Tofacitinib In Moderate To Severe Alopecia Areata, Totalis And Universalis
Status: Enrolling
Updated: 2/14/2017
Study To Evaluate The Efficacy Of Tofacitinib In Moderate To Severe Alopecia Areata, Totalis And Universalis
Updated: 2/14/2017
An Open-Label Pilot Study To Evaluate The Efficacy Of Tofacitinib In Moderate To Severe Alopecia Areata, Totalis And Universalis
Status: Enrolling
Updated: 2/14/2017
Click here to add this to my saved trials
Compression Headband Use to Prevent Hair Loss During Whole Brain Radiotherapy
Updated: 2/27/2017
Feasibility Clinical Study of Compression Headband Use to Prevent Hair Loss During Whole Brain Radiotherapy
Status: Enrolling
Updated: 2/27/2017
Compression Headband Use to Prevent Hair Loss During Whole Brain Radiotherapy
Updated: 2/27/2017
Feasibility Clinical Study of Compression Headband Use to Prevent Hair Loss During Whole Brain Radiotherapy
Status: Enrolling
Updated: 2/27/2017
Click here to add this to my saved trials
Tofacitinib for the Treatment of Alopecia Areata and Its Variants
Updated: 10/4/2017
Tofacitinib for the Treatment of Alopecia Areata and Its Variants
Status: Enrolling
Updated: 10/4/2017
Tofacitinib for the Treatment of Alopecia Areata and Its Variants
Updated: 10/4/2017
Tofacitinib for the Treatment of Alopecia Areata and Its Variants
Status: Enrolling
Updated: 10/4/2017
Click here to add this to my saved trials
A Study of Secukinumab for the Treatment of Alopecia Areata
Updated: 11/2/2017
An Exploratory Study to Evaluate the Safety and Efficacy of Secukinumab in the Treatment of Extensive Alopecia Areata
Status: Enrolling
Updated: 11/2/2017
A Study of Secukinumab for the Treatment of Alopecia Areata
Updated: 11/2/2017
An Exploratory Study to Evaluate the Safety and Efficacy of Secukinumab in the Treatment of Extensive Alopecia Areata
Status: Enrolling
Updated: 11/2/2017
Click here to add this to my saved trials
Alefacept in Patients With Severe Scalp Alopecia Areata
Updated: 11/22/2017
A Double-Blind, Placebo-Controlled, Randomized, Multi-Center Study to Evaluate The Safety and Therapeutic Efficacy of Intramuscular Administration of Alefacept in Patients With Chronic, Severe Scalp Alopecia Areata
Status: Enrolling
Updated: 11/22/2017
Alefacept in Patients With Severe Scalp Alopecia Areata
Updated: 11/22/2017
A Double-Blind, Placebo-Controlled, Randomized, Multi-Center Study to Evaluate The Safety and Therapeutic Efficacy of Intramuscular Administration of Alefacept in Patients With Chronic, Severe Scalp Alopecia Areata
Status: Enrolling
Updated: 11/22/2017
Click here to add this to my saved trials
Pilot Study of the Safety and Efficacy of Apremilast in Subjects With Moderate to Severe Alopecia Areata
Updated: 1/16/2018
A Randomized Placebo-controlled Single Center Pilot Study of the Safety and Efficacy of Apremilast in Subjects With Moderate to Severe Alopecia Areata
Status: Enrolling
Updated: 1/16/2018
Pilot Study of the Safety and Efficacy of Apremilast in Subjects With Moderate to Severe Alopecia Areata
Updated: 1/16/2018
A Randomized Placebo-controlled Single Center Pilot Study of the Safety and Efficacy of Apremilast in Subjects With Moderate to Severe Alopecia Areata
Status: Enrolling
Updated: 1/16/2018
Click here to add this to my saved trials
Alopecia Areata Registry
Updated: 2/15/2018
Alopecia Areata Registry and Immunogenetic Mechanisms
Status: Enrolling
Updated: 2/15/2018
Alopecia Areata Registry
Updated: 2/15/2018
Alopecia Areata Registry and Immunogenetic Mechanisms
Status: Enrolling
Updated: 2/15/2018
Click here to add this to my saved trials
Alopecia Areata Registry
Updated: 2/15/2018
Alopecia Areata Registry and Immunogenetic Mechanisms
Status: Enrolling
Updated: 2/15/2018
Alopecia Areata Registry
Updated: 2/15/2018
Alopecia Areata Registry and Immunogenetic Mechanisms
Status: Enrolling
Updated: 2/15/2018
Click here to add this to my saved trials
Alopecia Areata Registry
Updated: 2/15/2018
Alopecia Areata Registry and Immunogenetic Mechanisms
Status: Enrolling
Updated: 2/15/2018
Alopecia Areata Registry
Updated: 2/15/2018
Alopecia Areata Registry and Immunogenetic Mechanisms
Status: Enrolling
Updated: 2/15/2018
Click here to add this to my saved trials
Alopecia Areata Registry
Updated: 2/15/2018
Alopecia Areata Registry and Immunogenetic Mechanisms
Status: Enrolling
Updated: 2/15/2018
Alopecia Areata Registry
Updated: 2/15/2018
Alopecia Areata Registry and Immunogenetic Mechanisms
Status: Enrolling
Updated: 2/15/2018
Click here to add this to my saved trials
Alopecia Areata Registry
Updated: 2/15/2018
Alopecia Areata Registry and Immunogenetic Mechanisms
Status: Enrolling
Updated: 2/15/2018
Alopecia Areata Registry
Updated: 2/15/2018
Alopecia Areata Registry and Immunogenetic Mechanisms
Status: Enrolling
Updated: 2/15/2018
Click here to add this to my saved trials